Selection of down-regulated sequences along the monocytic differentiation of leukemic HL60 cells  by Herblot, S et al.
FEBS Letters 414 (1997) 146-152 FEBS 19115 
Selection of down-regulated sequences along the monocytic 
differentiation of leukemic HL60 cells 
S. Herblota, A. Vekrisb, A. Rouzautc, F. Najemea, C. de Miguelc, J.H. Beziana, J. Bonnets* 
"Lahoratoire d'Immunologie Moleculaire, Universite de Bordeaux II, Zone Nord hat. Ih, 146 Rue Leo Saignat, 33076 Bordeaux Cedex, France 
h Lahoratoire de Pathologie Moleculaire et de Therapie Genique, Universite de Bordeaux II, Zone Nord bat. Ih, 146 Rue Leo Saignat, 
33076 Bordeaux Cedex, France 
cDepartement de Biochemica, Universidad de Navarra, Appartado 177, 31080 Pampelona, Spain 
Received 25 June 1997 
Abstract In order to dissect the molecular mechanisms of 
monocytic differentiation we have developed a subtractive 
hybridisation method based on a simplified 'representational 
difference analysis'. We have selected 16 sequences and 
confirmed their down-regulation along the TPA-induced mono-
cytic differentiation of HL60 cells. Among these sequences we 
have identified the a-tubulin, the TaxREB protein and two 
ribosomal protein sequences which had not been previously 
described as differentially expressed. These results add to our 
knowledge about the molecules implicated along the monocytic 
differentiation and growth arrest of leukemic cells and provide a 
first step in the study of their respective roles. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The monocyte-macrophages are key components of the im-
mune system. They are multifunctional cells and participate in 
both specific and non-specific immune responses. When chal-
lenged by pathological agents or neoplastic growth, the mono-
cyte-macrophages are able to be activated and develop speci-
alised functions, such as phagocytosis, cytokine secretion, T-
cell antigen presentation process and stimulate the cell-medi-
ated immunity. They also actively participate in acute and 
chronic inflammation processes by infiltrating inflammation 
sites and secreting the inflammatory cytokines, interleukin-1, 
interleukin-6 and tumour necrosis factor, which mediate the 
recruitment and activation of other immune cells, such as 
neutrophils (reviewed in [1]). 
The monocytes develop in the bone marrow from multi-
potent hematopoietic precursors, under the influence of solu-
ble growth factors, such as GM-CSF, M-CSF, interleukin-3, 
and physical interactions with stromal cells (reviewed in [2]). 
Acquisition of the mature phenotype is accompanied by 
growth arrest and passage from the bone marrow to the 
bloodstream. Blood monocytes provide a common source of 
tissue macrophages. Monocytes infiltrate tissues and body 
cavities in response to yet unknown signals and develop into 
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resident macrophages, depending on the local microenviron-
ment. They acquire specialised phenotypes and functions, 
such as those exhibited by Kupffer cells in the liver, osteoclast 
in the bone or microglia in the brain [3]. 
The cell differentiation process needs an ordered gene ex-
pression regulation including both activation and repression 
of lineage-specific and ubiquitous genes, leading to growth 
arrest and acquisition of novel functions. The molecular 
mechanisms involved in this process have been partially 
understood, using in vitro models of monocytic differentiation 
such as the human myelomonocytic cell lines HL60 or U937 
induced by a variety of chemical agents including phorbol 
ester, 1,25-dihydroxyvitamin D3 or cytokines such as GM-
CSF [4]. Numerous reports focused on the transcription reg-
ulation by c-myc, c-fos and c-jun oncogenes or the PU.l, NF-
IL6 transcription factors, in order to define their key roles in 
monocytic differentiation [5-8]. The isolation of several HL60 
and U937 TPA-resistant variants allowed the characterisation 
of essential regulators such as different protein kinase C iso-
forms [9,10]. Furthermore, analyses of gene expression mod-
ulations by cDNA differential screening have lead to the iden-
tification of some molecules including the transcription factor 
Erg-1 [11], the Mpg-1 protein [12] or the monocyte serine 
esterase-1 [13], the expressions of which are enhanced along 
monocytic differentiation. 
Recently, 'representational difference analysis' (RDA) was 
developed to isolate genomic sequences containing mutations 
[14] and subsequently adapted to cDNA difference analysis by 
Hubank and Schatz [15]. To isolate the sequence differences 
between two nucleic acid populations, these methods use PCR 
amplification of DNA populations, DNA hybridisation in 
solution, enzyme digestion to remove shared sequences and 
target sequence selection by PCR. The subtracted product 
containing the target sequences can be directly cloned or la-
belled to screen cDNA libraries. By adapting the ratio be-
tween driver and tester amounts, this method has proved to 
efficiently isolate sequences present at different levels in driver 
and tester cDNA representations, as well as sequences present 
only in the tester representation [15]. We developed a similar 
procedure involving fewer steps, based on the simplified ge-
nomic RDA procedure described by Zhu [16] and adapted to 
cDNA populations. Moreover, our method presents the ad-
vantage of isolating qualitative and quantitative differences 
between mRNA populations in a single subtraction experi-
ment. 
Here we report the results obtained by the selection of 
sequences down-regulated along the monocytic differentiation 
of HL60 cell line induced by 12-0-tetradecanoylphorbol-13-
acetate (TPA). For cDNA subtraction, the driver cDNA was 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / /S0014-5793(97)00967-8 
S. Herblot et al.lFEBS Letters 414 (1997) 146-152 
prepared from differentiated cells and the tester cDNA was 
from uninduced cells. Sixteen clones were selected by a cDNA 
library screen with the subtracted product. They were subse-
quently confirmed to be differentially expressed and then, se-
quenced. Two of these sequences encode proteins already 
known as down-regulated along monocytic pathway whereas, 
five sequences encode proteins that have not been described as 
repressed along monocytic differentiation, among them, the oc-
tubulin protein, the TaxREB transcription factors, and ribo-
somal proteins. The last one corresponds to sequences not 
found in data bases. These results add to our knowledge 
about the molecules the expression of which is modulated 
after TPA-induced monocytic differentiation and provide the 
first step of the study of their respective roles along the mono-
cytic differentiation. 
2. Materials and methods 
2.1. Cell culture and differentiation 
The human promyelocytic cell line HL60 and the promonocytic cell 
line U937 were cultured in RPMI-1640 medium supplemented with 
10% foetal calf serum (Gibco, BRL), 4 mM L-glutamine, and 100 tig/ 
ml gentamicine. Cells were grown to a density of 106 cells per ml and 
then, induced to differentiate with 10 nM of TPA (Sigma). The mac-
rophage differentiation was controlled by morphologic assessment 
after May Grunwald Giemsma staining and cytofluorimetry using a 
fluorescein-CDllc antibody (Sigma). 
2.2. RNA preparations 
Total and poly(A)+ RNA were respectively prepared by guanidine 
isothiocyanate method [17] and poly Attract System 1000 kit (Prom-
ega). 
2.3. Oligonucleotides 
UPdN6 GCCGGAGCTGCAGAATTCNNNNNN 
UP GCCGGAGCTGCAGAATTC 
AD1 CGGGAATTCGCTCGACATG 
T3 ATTAACCCTCACTAAAGGGA 
T7 TAATACGACTCACTATAGGG 
2.4. Subtractive cDNA hybridisation in solution 
For driver cDNA synthesis, 2 ug of poly(A)+ RNA was used to 
synthesise random double-stranded cDNA, as described by P. Frous-
sard [18] with a few modifications. Briefly, the first-strand cDNA 
synthesis reaction was set up combining the mRNA template, 100 
ng of UPdN6 primer, 5X RT-buffer, 1 U of RNAse inhibitor (RNA-
sin, Promega), 100 U of M-MLV reverse transcriptase (Promega, 
France) in a final volume of 12.5 ul; the mixture was incubated at 
37°C for 2 h then heated at 99°C for 2 min. Second-strand cDNA 
synthesis was achieved by adding DNA polymerase buffer, 0.3 mM of 
each dNTP, 5 U of Klenow fragment (Promega, France) in a final 
volume of 50 ul. The mixture was incubated at 37°C for 20 min. The 
double-stranded cDNA was purified on a Sephacryl S400 HR spin 
column (Pharmacia). Multiple PCR reactions were set up combining 
5 ul of purified cDNA, 1 uM of UP primer, 0.2 mM of each dNTP, 
1.5 mM MgCl2, 10 X Taq polymerase buffer and 0.4 U of Taq Poly-
merase (Goldstar, Eurogentec) in a final volume of 100 ul, then 30 
cycles were performed (94°C for 1 min, 55°C for 1 min, 72°C for 3 
min). The amplifiates were purified on Sephacryl S400 HR spin col-
umns and the quantification was performed by spectrophotometry at 
260 nm. 
Double-stranded tester cDNA synthesis was performed as described 
previously [19]. The first strand was primed with an anchored oli-
go(dT) carrying a 7VMII restriction site at the 5' end. The cDNA 
was purified on a Sephacryl spin column and precipitated with 1 
volume of isopropanol and 0.1 volume of sodium acetate (3 M, pH 
4). Then JVMII digestion was performed with 10 U of JVMII enzyme 
(Biolabs, New England) at 37°C for 6 h. After cDNA precipitation, 
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the AD1 oligonucleotide was ligated in a reaction mixture combining 
the digested cDNA, 200 ng of AD1, the ligation buffer and 0.5 mM 
ATP in a final volume of 9 ul. Heating at 50°C and cooling to 10°C 
over a period of 50 min performed the annealing of AD1 to the 3' 
protruding cDNA ends. Then, 1 U of T4 DNA ligase (Promega, 
France) was added and the medium was incubated at 14°C for 12 
h. After enzyme inactivation (70°C for 10 min) the 3' ends were filled 
in by adding 0.3 mM of each dNTP, DNA polymerase buffer and 5 U 
of Klenow fragment, in a final volume of 20 ul and the mixture was 
incubated at 37°C for 10 min, then the enzyme was heat inactivated at 
70°C for 10 min. Excess AD1 was removed by purification on a 
Sephacryl spin column and quantification of the remaining tester 
cDNA was performed by staining with colloidal gold (Genogold, 
Tebu), according to the manufacturer's instructions. 
For subtractive hybridisation, 50 ug of driver cDNA and 250 ng of 
tester cDNA were co-precipitated. The pellet was ethanol-washed and 
resuspended in 4 ul of hybridisation buffer (30 mM HEPES, pH 8, at 
20°C, 1 mM EDTA). After denaturation (99°C for 7 min), the salt 
concentration was adjusted to 1 M NaCl with 1 ul of 5 M NaCl and 
the cDNA was allowed to anneal for 24 h at 68°C. Then the reaction 
mixture was 5-fold diluted and the DNA was precipitated with iso-
propanol. The SI nuclease digestion was carried out in a final volume 
of 50 ul of 1 X nuclease buffer with 25 U of SI nuclease (Promega) at 
22°C for 30 min. The amount of enzyme must be adjusted for each 
batch. The pH of the reaction was adjusted to 7.0 with 0.2 ul of 2 M 
NaOH and the reaction was phenol/chloroform extracted, isopropa-
nol precipitated in the presence of an additional 25 ug of driver 
cDNA. After centrifugation and ethanol wash, the pellet was resus-
pended in 4 ul of hybridisation buffer for a second and a third round 
of subtraction in the same conditions as above. After purification on a 
Sephacryl spin column, the selective amplification was performed with 
2 ul of subtraction mixture, 1 uM of AD1, 1.5 mM MgCl2, 1 X Taq 
DNA polymerase buffer and 0.4 U of Taq DNA polymerase (Gold-
star, Eurogentec). 
2.5. cDNA library screen 
An HL60 cDNA library was constructed using the lambda ZAPII 
cloning kit (Stratagene). The mRNA prepared from uninduced, TPA-
induced cells and DMSO-induced cells were pooled to obtain a rep-
resentative library of the HL60 phenotypes. The cDNA library screen 
was performed as described [19]. The subtracted probe was labelled by 
PCR in the same conditions as above, including 0.2 mM of digoxige-
nin-dUTP in the dNTP mix and decreasing dTTP to 0.5 mM. 
2.6. Sequencing and database searches 
The sequencing reactions were performed with the Autoread se-
quence kit (Pharmacia) according to the manufacturer's instructions, 
using the T3 and T7 fluorescein end labelled primers. The sequence 
gels were run on an ALF automatic sequencer (Pharmacia). The 
comparisons to Genbank and EMBL databases were performed 
with Blast program [20]. 
2.7. Northern blot and dot-blot analyses 
Five micrograms of total RNA per lane were size fractionated on 
1.2% agarose gel containing 2.5% formaldehyde and transferred on a 
nylon membrane positively charged (Appligene). Hybridisations and 
chemiluminescent detection of digoxigenin-labelled probes were per-
formed as previously described [21]. The filters were exposed to XAR-
Biomat film (Kodak) for times ranging from 6 to 24 h. The amount of 
transferred RNA was controlled by staining the blots with colloidal 
gold (Genogold, Tebu). The digoxigenin-labelled probes used in 
Northern and dot-blots analyses were synthesised by PCR using the 
vector T3 and T7 primers in the same conditions as above. 
Random cDNAs were synthesised from poly(A)+ RNA of differ-
entiated and undifferentiated cells as above for driver synthesis [18]. 
Hybridisation and revelation steps were conducted as for Northern 
blots. 
3. Results 
3.1. Subtractive hybridisation 
The promyelocytic cell line HL60 was stimulated by 10 nM 
of TPA for 48 h and the macrophage phenotype was con-
trolled by microscopic observations of cell adherence, cell ag-
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Fig. 1. Outline of the cDNA subtractive procedure. For details see text. 
gregation and morphology after MGG staining, as well as 
FACS analysis of the CD lie expression [22] (data not 
shown). 
To isolate the sequences down-regulated during the matu-
ration process, a cDNA subtraction procedure was performed 
(Fig. 1). The driver cDNA was randomly synthesized with a 
degenerated hexanucleotide carrying an 'universal-primer' 
(UP) at the 5' end [18]. The length of the second-strand 
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Fig. 2. Differential expression of seven clones isolated by the cDNA 
subtraction procedure. Random-PCR cDNAs from undifferentiated 
(ProM) and TPA-differentiated (M<D) HL60 cells were dotted on ny-
lon membranes. Hybridisations were performed with digoxigenin-la-
belled probes corresponding to the repressed sequences. The 
amounts of dotted cDNA were controlled either by hybridisation 
with a total cDNA probe (Total) or by direct staining with colloidal 
gold (G). 
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these cDNA molecules. After three rounds of hybridisation/Si 
nuclease digestion the specific tester sequences still carrying 
the AD1 sequence were selectively amplified. 
The specificity of the subtracted product was checked by 
hybridisation on dot-blots of tester and driver cDNA gener-
ated by random-PCR. As expected, the subtracted product 
gave a hybridisation signal higher with the cDNA obtained 
from undifferentiated cells than with the cDNA obtained from 
differentiated cells (data not shown). 
3.2. cDNA library screen 
The resulting subtracted product was digoxigenin-labelled 
and used to screen 25 000 clones of a HL60 cDNA library. 
Forty-five positive clones were selected and cross-hybridised 
to eliminate redundant sequences. As a first control for differ-
ential expression of the isolated sequences, each of them was 
digoxigenin-labelled and hybridised on dot-blots of cDNA 
amplifiates prepared from differentiated and undifferentiated 
cells (Fig. 2). The amounts of dotted cDNA were controlled 
either by hybridisation with a total cDNA probe or by direct 
DNA staining with colloidal gold. Both methods gave similar 
results. All the tested sequences showed a decrease in their 
expression levels but some of them are still expressed in differ-
entiated cells. 
cDNA ranged from 200 to 800 bp, with an average of 500 bp, 
making these molecules amplifiable with the same efficiency 
using UP. Parallel amplification reactions were run to obtain 
enough driver cDNA for an efficient subtraction. 
For the tester preparation, the cDNA synthesis was initi-
ated with an oligo(dT) carrying a 3' degenerated nucleotide 
(to avoid getting a long poly(dT) stretch) and a Mall l restric-
tion site at the 5' end. The double-stranded cDNA was re-
stricted with this 4-cutter enzyme and the AD1 oligonucleo-
tide was ligated at the 5' ends. Then the 3' ends were filled in 
to generate amplifiable blunt end molecules. We choose Mall l 
enzyme to ensure that most cDNA molecules would be cut at 
least once; the length of restricted cDNA molecules was quite 
homogeneous, with an average of 300 bp, so all these frag-
ments can be expected to be amplified with the same effi-
ciency. 
The tester and the driver were mixed in a ratio of 1:200 and 
allowed to hybridise at 68°C for 24 h. Then, the SI nuclease 
digestion removed the non-hybridised ends of the tester/driver 
hetero-hybrids, making these molecules non-amplifiable. For 
the second and third round of subtraction an additional 
amount of driver was added to compensate the loss of driver 
during SI nuclease digestion because of the random nature of 
3.3. Sequencing of the selected clones 
Sixteen clones were further characterised by sequencing and 
comparison to Genbank and EMBL databases. The results 
are summarised in Table 1. The myeloperoxidase (MPO) 
and the far upstream sequence element-binding protein 
(FUSE-BP) were previously described as differentially ex-
pressed along monocytic differentiation [31-33]. The ND46 
sequence matched equally the CREB-2 and TaxREB67 se-
quences, which are two members of the ATF/CREB transcrip-
tion factor family. 
3.4. Kinetic of expression of the selected clones 
The decrease in oc-tubulin, RBP P0, TaxREB107, and MPO 
mRNA amounts were investigated along macrophage differ-
entiation. The HL60 cells were collected at various times after 
the TPA induction (0, 30 min, 1 h, 24 h, and 48 h) and total 
RNA were submitted to Northern blot analyses. The c-myc 
and c-fos mRNA levels were also determined as controls. The 
decrease in c-myc expression correlates with the growth arrest 
of the mature cells, and the increase in c-fos expression corre-
lates with the increase in activity of the API transcription 
factor [34]. 
Fig. 3 shows a rapid 2-fold decrease in oc-tubulin mRNA 
Table 1 
Sequencing results of the 16 selected clones 
Clone numbers Identification References 
ND51, ND 35 
ND45 
ND46 
ND22, ND25, ND26 
ND11 
ND5, ND28, ND34, ND 39, ND40 
ND21 
ND38 
BqND5 
Myeloperoxidase 
FUSE-binding protein 
CREB-2 and TaxREB67 
a-Tubuline 
TaxREB107 
RBPP0 
RBP L17 
Non-identified 
Alu sequence repeat 
[23] 
[24] 
[25,26] 
[27] 
[28] 
[29] 
[30] 
Comparisons to Genbank and EMBL databases were performed with Blast softwares. The sequences were submitted to Genbank database; the 
accession numbers are AF004537 to AF004552. 
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Fig. 3. mRNA levels of selected clones along the differentiation 
process. Five micrograms of total RNA per lane were size fractio-
nated on a 1.2% agarose formaldehyde gel and transferred on nylon 
membranes. Probes corresponding to RBP P0, a-tubulin, MPO, c-
myc, c-fos mRNAs were digoxigenin-labelled. Hybridisation and rev-
elation were performed as described in Section 2. The loading and 
transfer of the RNAs were checked by direct staining with colloidal 
gold. 
within 30 min after the TPA stimulation and after 48 h, the 
signal was barely visible with non-radioactive Northern blot 
detection. TaxREB107 and RBP P0 mRNA levels decrease 
significantly after 24 h of TPA stimulation. The results ob-
tained for MPO mRNA were consistent with those previously 
described [30,31]. 
We also investigated the mRNA levels along the TPA-in-
duced differentiation of the myelomonocytic cell line U937. 
These cells are more mature than HL60 cells and do not 
express the MPO mRNA. We observed comparable down-
regulations for TaxREB107 and RBP P0 mRNAs, but not 
for a-tubulin mRNA. 
So the subtraction-selected sequences showed different ki-
netic decreases suggesting that different mechanisms are in-
volved in controlling their mRNA levels. Some may be related 
to the cell proliferative state and other may be related to the 
maturation stage. 
4. Discussion 
The aim of this work was to isolate and characterise mol-
ecules implicated in macrophage differentiation, in order to 
dissect the molecular mechanisms of this physiological proc-
ess. A subtractive cDNA hybridisation was performed to iso-
late the sequences down-regulated after TPA-induced differ-
entiation of the HL60 cell line. 
Our results show that the simplified RDA procedure de-
scribed here efficiently generates cDNA enriched for differen-
tially expressed genes of both high and low abundance. 
Housekeeping genes as well as transcription factors have 
been identified, with no false-positives among the 16 clones 
analysed. Moreover, qualitative and quantitative changes in 
mRNA levels can be detected in a single subtractive proce-
dure. Indeed, we identified either sequences present only in 
uninduced cells, or sequences down-regulated but still ex-
pressed in differentiated cells. The previously described 
cDNA RDA and suppression subtractive hybridisation 
(SSH) procedures need multiple subtractions with various 
driver/tester ratios to select the sequences presenting quanti-
tative differences between the two cDNA representations 
[15,35]. 
We have identified five down-regulated species, among 
which two encode ribosomal proteins, RBP LI7 and 
RBP P0. Our results add information to the previously re-
ported observations of the down-regulation of several other 
ribosomal proteins after the chemical-induced differentiation 
of leukemic cells [36,37]. Some ribosomal proteins are often 
overexpressed in cancer cells and the growth arrest of the cells 
is often associated with the normalisation of their expression. 
This over-expression of ribosomal proteins is not correlated to 
an over-expression of all the transcriptional machinery: there 
is a tissue and stage specificity of the over-expressed species, 
suggesting a specific role for each ones in the proliferation 
and/or differentiation. The specialised functions of the riboso-
mal proteins remain to be understood. Some of them may 
differently affect the translation of certain mRNA as do the 
acidic ribosomal proteins PI and P2 in Saccharomyces cerevi-
siae [38]. The fact that the amount of RBP P0 mRNA is 
weaker in undifferentiated U937 than in undifferentiated 
HL60 cells suggests that the mRNA level of this ribosomal 
protein is rather correlated to the maturation stage of the cells 
than to the proliferative state. 
The acquisition of the mature macrophage phenotype is 
characterised by morphological changes including cell adher-
ence, pseudopodia formation and phagocytosis. These 
changes are dependent on the reorganisation of the cyto-
skeletal networks, in particular the microtubules and the mi-
crofilaments [39,40]. The chemical-induced depolymerisation 
of the microtubule network potentiates the TPA-induced 
monocytic differentiation of leukemic cell lines, suggesting a 
role of the microtubules in some signal transduction pathways 
[41]. The protein kinase C activation induced by TPA leads to 
a-tubulin and microtubule-associated protein phosphoryla-
tions and, as a consequence, to the destabilisation of the mi-
crotubules architecture and an increase in the microtubule 
depolymerisation [42]. It has been recently reported that this 
depolymerisation is crucial for the early stages of the U937 
cell differentiation induced by TPA. U937 variants lacking 
cytoskeletal reorganisation and (32-integrins translocation to 
the cell membrane after TPA-stimulation, fail to acquire a 
mature macrophage phenotype [10]. So, this cytoskeletal re-
organisation appears to be a prerequisite for complete mono-
cytic maturation and transcriptional activation of genes such 
as CDllb and c genes. Furthermore, it has been reported that 
the modification of soluble to polymeric tubulin ratio directly 
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regulates the expression of some genes such as the urokinase-
type plasminogen activator gene [43,44] and regulates the ac-
tivities of the N F - K B transcription factor and c-Myc protein 
[45,46]. Our Northern blot analysis indicates a rapid decrease 
in the a-tubulin mRNA level after 30 min of TPA-stimulation 
of HL60 cells, suggesting that the mechanism involved in the 
early stage would rather be a decrease in the mRNA stability 
than a modification of the transcription rate. An autoregula-
tion of the a-tubulin mRNA stability by the soluble protein 
has been suggested by several reports as a way of controlling 
the polymeric to soluble tubulin ratio [47]. Surprisingly, no 
decrease in mRNA level was observed between unstimulated 
and 48 h TPA-stimulated U937 cells, but a transient decrease 
after TPA-addition cannot be excluded. 
Taken together, these results indicate that the cytoskeleton 
does not have only a mechanic role in monocyte biology: the 
microtubules participate actively to the regulation of gene ex-
pression and our results show that the regulation mechanisms 
involving microtubules seem to occur not only at the post-
translational but also at the synthesis levels. 
The TaxREB107 protein is a leucine zipper transcription 
factor that binds specifically the Tax responsive enhancer el-
ement in the long terminal repeat of the human T-cell leuke-
mia virus type I. It was isolated from the human T-cell line 
Jurkat, but significant levels of TaxREB107 mRNAs were 
observed in all cell lines and tissues analysed [27]. This factor 
acts together with other cellular factors such as ATF and 
CREB to mediate trans-activation of the viral protein Tax 
[48]. The down-regulation of both CREB and TaxREB107 
mRNAs suggests a possible cooperation between these tran-
scription factors in some gene expression regulations even in 
the absence of HTLV-1 Tax protein. The physiological func-
tion of TaxREB107 in non-infected cells, is not yet known, 
however, its constitutive and ubiquitous expression argues for 
an important and biologically conserved function. Here we 
have shown that the TaxREB107 mRNA level dramatically 
decreases along monocytic differentiation of HL60 and U937 
cell lines. Moreover, the TaxREB107 mRNA level is com-
parable in both proliferating cell lines and so, it seems to be 
related to the proliferative state rather than to the maturation 
stage. It has been reported previously an increase in Tax-
REB107 mRNA level in Jurkat cells after TPA stimulation 
which leads to an increase in growth rate [49]. In all cases the 
maximal expression of this factor is associated with the pro-
liferative stage of the cells. It will be interesting to identify the 
consensus recognition sequence of this transcription factor 
and its target genes to appreciate its function in macrophage 
differentiation and T-cell activation. 
As a conclusion, we developed a subtractive hybridisation 
procedure which can be applied to very low amounts of start-
ing material and seems to give very few false-positive clones, 
which is a major drawback in many subtractive procedures. 
This procedure allowed us to identify several sequences down-
regulated during HL60 leukemic cell differentiation. The data 
reported here may provide new approaches in the study of 
myeloid differentiation and proliferation arrest. 
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